DRACEA INVEST ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.1% 19.1% 5.1% 6.8% 5.2%  
Credit score (0-100)  21 7 42 35 42  
Credit rating  BB B BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -5.8 -5.3 -5.1 77.9 -1.6  
EBITDA  -5.8 -5.3 -5.1 77.9 -1.6  
EBIT  -5.8 -5.3 -5.1 77.9 -1.6  
Pre-tax profit (PTP)  185.6 133.6 -19.1 27.1 24.5  
Net earnings  146.3 104.0 -14.9 18.0 18.9  
Pre-tax profit without non-rec. items  186 134 -19.1 27.1 24.5  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  309 413 398 358 377  
Interest-bearing liabilities  0.8 0.5 0.8 10.0 3.8  
Balance sheet total (assets)  353 446 430 410 381  

Net Debt  -352 -446 -349 -25.6 -80.4  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5.8 -5.3 -5.1 77.9 -1.6  
Gross profit growth  0.0% 9.3% 3.8% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  353 446 430 410 381  
Balance sheet change%  4.5% 26.3% -3.7% -4.6% -7.0%  
Added value  -5.8 -5.3 -5.1 77.9 -1.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  54.5% 33.7% 0.3% 17.3% 6.2%  
ROI %  58.8% 37.3% 0.3% 19.0% 6.5%  
ROE %  62.2% 28.8% -3.7% 4.8% 5.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  87.3% 92.5% 92.5% 87.4% 99.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  6,022.7% 8,408.8% 6,838.5% -32.9% 4,913.3%  
Gearing %  0.3% 0.1% 0.2% 2.8% 1.0%  
Net interest  0 0 0 0 0  
Financing costs %  3.3% 190.0% 3,252.4% 846.2% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  7.9 13.3 12.7 7.7 98.8  
Current Ratio  7.9 13.3 12.7 7.7 98.8  
Cash and cash equivalent  352.7 446.1 349.6 35.6 84.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -14.0 412.5 73.7 313.3 294.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0